
Cognyte Software Ltd. CGNT
$ 8.37
0.12%
Annual report 2025
added 03-07-2026
Cognyte Software Ltd. P/CF Ratio 2011-2026 | CGNT
Annual P/CF Ratio Cognyte Software Ltd.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 14.1 | 13.6 | -9.37 | 129 | 10 | 6.23 | 6.24 | - | 117 | 37.9 | -8.44 | -22.2 | -13.2 | -17.6 | -81.2 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 129 | -81.2 | 13 |
P/CF Ratio of other stocks in the Medical devices industry
| Issuer | P/CF Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Aethlon Medical
AEMD
|
-0.396 | $ 2.2 | -0.45 % | $ 3.43 M | ||
|
Acutus Medical
AFIB
|
-0.083 | - | -26.83 % | $ 2.62 M | ||
|
Allied Healthcare Products
AHPI
|
-0.98 | - | 3.58 % | $ 2.21 M | ||
|
AdaptHealth Corp.
AHCO
|
2 | $ 10.54 | 0.86 % | $ 1.42 B | ||
|
GenMark Diagnostics, Inc.
GNMK
|
-80.1 | - | - | $ 1.77 B | ||
|
Alphatec Holdings
ATEC
|
45.7 | $ 12.8 | -1.92 % | $ 1.92 B | ||
|
Lianluo Smart Limited
LLIT
|
-62.7 | - | 24.59 % | $ 44.8 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
-3.31 | - | -5.86 % | $ 30.6 M | ||
|
ClearPoint Neuro
CLPT
|
-13.2 | $ 9.78 | -12.37 % | $ 277 M | ||
|
Avinger
AVGR
|
-0.18 | - | -20.74 % | $ 369 K | ||
|
Aziyo Biologics
AZYO
|
-1.24 | - | 1.37 % | $ 20.5 M | ||
|
Butterfly Network
BFLY
|
-18.4 | $ 4.04 | -5.28 % | $ 855 M | ||
|
BIOLASE
BIOL
|
-0.0136 | - | -13.19 % | $ 166 K | ||
|
Cytosorbents Corporation
CTSO
|
-3.77 | $ 0.66 | -3.66 % | $ 35.9 M | ||
|
Conformis
CFMS
|
-0.252 | - | - | $ 16.4 M | ||
|
Boston Scientific Corporation
BSX
|
24.9 | $ 71.52 | 0.38 % | $ 106 B | ||
|
Apollo Endosurgery
APEN
|
-12.9 | - | - | $ 475 M | ||
|
EDAP TMS S.A.
EDAP
|
-4.42 | $ 3.86 | -4.93 % | $ 144 M | ||
|
CONMED Corporation
CNMD
|
7.72 | $ 36.87 | -0.83 % | $ 1.14 B | ||
|
Establishment Labs Holdings
ESTA
|
-45.5 | $ 64.93 | -0.12 % | $ 1.92 B | ||
|
CryoLife, Inc.
CRY
|
180 | - | -4.14 % | $ 702 M | ||
|
Cutera
CUTR
|
-0.337 | - | -10.19 % | $ 1.99 M | ||
|
InMode Ltd.
INMD
|
10.9 | $ 13.45 | -1.47 % | $ 869 M | ||
|
CHF Solutions, Inc.
CHFS
|
-0.0621 | - | 1.15 % | $ 34.5 M | ||
|
Dynatronics Corporation
DYNT
|
6.49 | - | 14.99 % | $ 929 K | ||
|
Axonics Modulation Technologies
AXNX
|
885 | - | - | $ 3.31 B | ||
|
Soliton, Inc.
SOLY
|
-18.5 | - | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
-1.02 | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
-30.7 | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
-6.81 | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
-25 | - | - | $ 111 M | ||
|
FONAR Corporation
FONR
|
5.57 | $ 18.44 | -0.05 % | $ 121 M | ||
|
Intersect ENT, Inc.
XENT
|
-20.1 | - | - | $ 955 M | ||
|
GBS
GBS
|
-0.256 | - | -0.57 % | $ 7.12 M | ||
|
Abbott Laboratories
ABT
|
20.5 | $ 107.89 | -2.58 % | $ 188 B | ||
|
IRIDEX Corporation
IRIX
|
-7.13 | $ 1.33 | - | $ 21.5 M | ||
|
Delcath Systems
DCTH
|
14.5 | $ 9.45 | -2.98 % | $ 339 M | ||
|
Bio-Rad Laboratories
BIO
|
17.2 | $ 270.01 | 0.23 % | $ 7.62 B | ||
|
OrthoPediatrics Corp.
KIDS
|
-90 | $ 16.7 | -2.96 % | $ 392 M | ||
|
Helius Medical Technologies
HSDT
|
-0.34 | $ 2.1 | -3.46 % | $ 1.28 M | ||
|
AxoGen
AXGN
|
1.84 K | $ 31.03 | -5.25 % | $ 1.43 B | ||
|
Align Technology
ALGN
|
18.9 | $ 173.18 | -1.67 % | $ 13 B | ||
|
Integra LifeSciences Holdings Corporation
IART
|
14.5 | $ 8.9 | -2.25 % | $ 685 M | ||
|
Bruker Corporation
BRKR
|
0.000028 | $ 34.44 | 2.07 % | $ 5.13 K | ||
|
BioSig Technologies
BSGM
|
-1.53 | - | 37.08 % | $ 85.7 M | ||
|
Apyx Medical Corporation
APYX
|
-17.7 | $ 3.7 | -1.07 % | $ 152 M | ||
|
Second Sight Medical Products
EYES
|
-0.0108 | - | -0.97 % | $ 54.4 M | ||
|
Accuray Incorporated
ARAY
|
56.1 | $ 0.42 | 7.69 % | $ 43.2 M | ||
|
IRadimed Corporation
IRMD
|
50.2 | $ 101.65 | -1.12 % | $ 1.29 B |